Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Rating of “Reduce” from Analysts

Oscar Health, Inc. (NYSE:OSCR) has received a consensus recommendation of “Reduce” from the eleven research firms that are covering the company, Marketbeat reports. Four research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $15.5714.

A number of research firms recently commented on OSCR. Stephens initiated coverage on Oscar Health in a report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 price objective on the stock. Wells Fargo & Company reduced their target price on Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. The Goldman Sachs Group began coverage on Oscar Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price objective for the company. Finally, Barclays boosted their price objective on shares of Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a report on Monday, November 10th.

Oscar Health Stock Down 0.1%

Shares of OSCR opened at $14.92 on Friday. Oscar Health has a 52-week low of $11.20 and a 52-week high of $23.80. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The stock has a fifty day simple moving average of $16.57 and a two-hundred day simple moving average of $17.05. The company has a market capitalization of $3.95 billion, a PE ratio of -13.32 and a beta of 1.88.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. The company had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. Oscar Health’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.22) earnings per share. As a group, equities analysts forecast that Oscar Health will post 0.69 EPS for the current year.

Insider Activity at Oscar Health

In related news, CFO Richard Scott Blackley sold 25,135 shares of Oscar Health stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $416,989.65. Following the completion of the sale, the chief financial officer owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. This trade represents a 1.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Adam Mcananey sold 1,852 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $30,724.68. Following the completion of the sale, the insider directly owned 179,241 shares in the company, valued at approximately $2,973,608.19. The trade was a 1.02% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 344,472 shares of company stock worth $5,337,030. Company insiders own 24.39% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. IFP Advisors Inc grew its position in Oscar Health by 2,762.6% in the 3rd quarter. IFP Advisors Inc now owns 6,498 shares of the company’s stock valued at $123,000 after acquiring an additional 6,271 shares in the last quarter. Cantor Fitzgerald L. P. lifted its position in shares of Oscar Health by 2.2% during the third quarter. Cantor Fitzgerald L. P. now owns 125,144 shares of the company’s stock worth $2,369,000 after purchasing an additional 2,637 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of Oscar Health in the third quarter valued at approximately $392,000. EMC Capital Management grew its holdings in shares of Oscar Health by 336.7% in the third quarter. EMC Capital Management now owns 13,100 shares of the company’s stock valued at $248,000 after purchasing an additional 10,100 shares in the last quarter. Finally, Advisory Services Network LLC increased its stake in Oscar Health by 390.1% during the 3rd quarter. Advisory Services Network LLC now owns 39,235 shares of the company’s stock worth $743,000 after buying an additional 31,229 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.